MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0026723
Immunoconcept India Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.02 Cr
▲ 25% YoY
Net profit · FY 2025
₹4.42 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹7.06 Lakh
EBITDA margin 0.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹7.45 Cr
Satisfied ₹2.65 Cr
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Immunoconcept India Private Limited
Data last updated:
Immunoconcept India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 24 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2015PTC279473. Its GSTIN is 07AADCI8100K1ZN (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harendra Kumar and Laxmi Narain Dandona.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.426 First Floor Fie Patparganj Industrial Area, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.02 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹4.42 Lakh (net margin 0.4%) and EBITDA of ₹7.06 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company is associated with 1 brand: Immunoconcept India. As per MCA filings, the company has open charges of ₹7.45 Cr and satisfied charges of ₹2.65 Cr on record.
Immunoconcept India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0026723). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website immunoconceptindia.co.
Company details
CIN U74999DL2015PTC279473
Registration Number 279473
Incorporation Date 24 April 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0026723
Recognitions & Rankings of Immunoconcept India
Contact details
Immunoconcept India Private Limited's registered office is in New Delhi, Delhi. Its website is immunoconceptindia.co. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.426 First Floor Fie Patparganj Industrial Area, New Delhi, Delhi, India – 110092
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Immunoconcept India Private Limited, buy the company report.
Comprehensive company report
Immunoconcept India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Immunoconcept India operates one associated brand: Immunoconcept India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic instruments and kits for healthcare testing are supplied by Immunoconcept India. | immunoconceptindia.co |
Business activity
The main business activity of Immunoconcept India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Immunoconcept India Private Limited, buy the company report.
Financials of Immunoconcept India Private Limited
FY 2025 filings availableImmunoconcept India Private Limited reported revenue of ₹12.02 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹12.02 Cr ▲ 25%
Net profit · FY 2025
₹4.42 Lakh margin 0.4%
EBITDA · FY 2025
₹7.06 Lakh margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 9%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 58%
3 years · compounded
▼ 59%
5 years · compounded
▼ 37%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 25% growth in the latest year. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immunoconcept India Private Limited, buy the company report.
Board of directors of Immunoconcept India Private Limited
Immunoconcept India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harendra Kumar | Director | 24 Apr 2015 | 11 Years 6 Months | Current |
| Laxmi Narain Dandona | Director | 24 Apr 2015 | 11 Years 6 Months | Current |
Peer comparison
Immunoconcept India Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Immunoconcept India Private Limitedthis company | ₹12.02 Cr (FY 2025) | ₹4.42 Lakh | 0.4% | 25.0% | New Delhi, Delhi, India | |
| Metatech Medical Private Limited | ₹9.71 Cr (FY 2025) | 4.0% | Delhi, India | |||
| Elicad Pharmaceuticals Private Limited | ₹9.66 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Avco Consultancy Services Private Limited | ₹9.66 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Sushruta Surgicals Private Limited | ₹9.58 Cr (FY 2025) | 39.0% | Bhubaneswar, Odisha, India | |||
| Perfect Engitech & Healthcare Solutions Private Limited | ₹9.55 Cr (FY 2025) | -20.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Immunoconcept India Private Limited, buy the company report.
Auditor
Immunoconcept India Private Limited is audited by SUNIL ANIL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL ANIL & ASSOCIATES | FY 2024 | 007464N |
Shareholding
The shareholding of Immunoconcept India Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Immunoconcept India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.45 Cr
Satisfied charges
₹2.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Mar 2024 | 100913193 | Hdfc Bank Limited | ₹1.53 Cr | Open | |
| 29 Nov 2023 | 100832035 | Others | ₹4.78 Cr | Open | |
| 15 Dec 2021 | 100522822 | Axis Bank Limited | ₹1.15 Cr | Open | |
| 23 Mar 2022 | 100581325 | Hdfc Bank Limited | ₹2.65 Cr | Satisfied |
To see the full charge records of Immunoconcept India Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Immunoconcept India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunoconcept India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Immunoconcept India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCI8100K1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Immunoconcept India Private Limited, buy the company report.
Recent activity
Immunoconcept India Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Harendra Kumar ceased to be Whole-Time Director on 30 Mar 2019.
AGM
Immunoconcept India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Immunoconcept India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 152.50 Lakh with Charge ID 100913193 was registered on 05 Mar 2024.
Charges
A charge registered on 23 Mar 2022 via Charge ID 100581325 with Hdfc Bank Limited was fully satisfied on 08 Jan 2024.
Charges
A charge with Others amounted to Rs. 477.68 Lakh with Charge ID 100832035 was registered on 29 Nov 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 265.00 Lakh registered on 23 Mar 2022 with Charge ID 100581325 was modified on 28 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 265.00 Lakh with Charge ID 100581325 was registered on 23 Mar 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 115.29 Lakh with Charge ID 100522822 was registered on 15 Dec 2021.
Ceased
Harendra Kumar ceased to be Whole-Time Director.
Ceased
Laxmi Narain Dandona ceased to be Whole-Time Director.
Appointed
Harendra Kumar was appointed as Director.
Appointed
Laxmi Narain Dandona was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Immunoconcept India is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 24 April 2015 (11+ years old) and is registered under CIN U74999DL2015PTC279473.
Immunoconcept India has 2 current directors:
- Harendra Kumar - Director
- Laxmi Narain Dandona - Director
The latest financial statements of Immunoconcept India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Immunoconcept India is 07AADCI8100K1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Immunoconcept India is U74999DL2015PTC279473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunoconcept India was incorporated on 24 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Immunoconcept India by revenue are Metatech Medical Private Limited, Elicad Pharmaceuticals Private Limited, Avco Consultancy Services Private Limited, Sushruta Surgicals Private Limited, Perfect Engitech & Healthcare Solutions Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Harendra Kumar ceased to be Whole-Time Director on 30 Mar 2019. Laxmi Narain Dandona ceased to be Whole-Time Director on 30 Mar 2019. Harendra Kumar was appointed as Director on 24 Apr 2015. Immunoconcept India has 4 board changes on record in total.
Yes, Immunoconcept India is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0026723).
Immunoconcept India can be reached through the website immunoconceptindia.co. Its registered office is in New Delhi, Delhi, India.
The registered office of Immunoconcept India is at Plot No.426 First Floor Fie Patparganj Industrial Area, New Delhi, Delhi, India – 110092.